UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Prophylaxis and Treatment against Klebsiella pneumoniae : Current Insights on This Emerging Anti-Microbial Resistant Global Threat

International journal of molecular sciences, 2021-04, Vol.22 (8), p.4042

2021

Volltextzugriff (PDF)

Advancing new vaccines against pandemic influenza in low-resource countries

Vaccine, 2017-09, Vol.35 (40), p.5397-5402

Berlanda Scorza, Francesco

2017

Volltextzugriff (PDF)

A flow cytometry-based assay to determine the ability of anti-Streptococcus pyogenes antibodies to mediate monocytic phagocytosis in human sera

Journal of immunological methods, 2024-05, Vol.528, p.113652-113652, Article 113652

2024

Volltextzugriff (PDF)

Towards a Four-Component GMMA-Based Vaccine against Shigella

Vaccines (Basel), 2022-02, Vol.10 (2), p.328

2022

Volltextzugriff (PDF)

High yield production process for Shigella outer membrane particles

PloS one, 2012-06, Vol.7 (6), p.e35616-e35616

2012

Volltextzugriff (PDF)

Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity

Vaccine, 2019-08, Vol.37 (35), p.4823-4829

2019

Volltextzugriff (PDF)

A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (6), p.2136451-2136451

2022

Volltextzugriff (PDF)

Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Shigella -specific antibodies

Frontiers in immunology, 2024, Vol.15, p.1374293-1374293

2024

Volltextzugriff (PDF)

Universal influenza vaccines: Shifting to better vaccines

Vaccine, 2016-06, Vol.34 (26), p.2926-2933

2016

Volltextzugriff (PDF)

Development and Application of a High-Throughput Method for the Purification and Analysis of Surface Carbohydrates from Klebsiella pneumoniae

Biology (Basel, Switzerland), 2024-04, Vol.13 (4), p.256

2024

Volltextzugriff (PDF)

A next-generation GMMA-based vaccine candidate to fight shigellosis

npj vaccines, 2023-09, Vol.8 (1), p.130-130, Article 130

2023

Volltextzugriff (PDF)

A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements

PLoS pathogens, 2009-12, Vol.5 (12), p.e1000710-e1000710

2009

Volltextzugriff (PDF)

Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adults

Vaccine, 2016-10, Vol.34 (45), p.5457-5462

2016

Volltextzugriff (PDF)

Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro

Journal of extracellular vesicles, 2013-01, Vol.2 (1), p.1-n/a

2013

Volltextzugriff (PDF)

New Kids on the Block: RNA-Based Influenza Virus Vaccines

Vaccines (Basel), 2018-04, Vol.6 (2), p.20

2018

Volltextzugriff (PDF)

GMMA-Based Vaccines: The Known and The Unknown

Frontiers in immunology, 2021-08, Vol.12, p.715393-715393

2021

Volltextzugriff (PDF)

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults

Human vaccines & immunotherapeutics, 2018-03, Vol.14 (3), p.579-586

2018

Volltextzugriff (PDF)

Vaccines for a sustainable planet

Science translational medicine, 2023-03, Vol.15 (685), p.eadf1093

2023

Volltextzugriff (PDF)

Self-Amplifying mRNA Vaccines

Advances in genetics, 2015, Vol.89, p.179

2015

Volltextzugriff (PDF)

Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus

Carbohydrate polymers, 2023-07, Vol.311, p.120736-120736, Article 120736

2023

Volltextzugriff (PDF)

Development and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human sera

Journal of immunological methods, 2024-03, Vol.526, p.113618-113618, Article 113618

2024

Volltextzugriff (PDF)

Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers

Vaccine, 2016-10, Vol.34 (45), p.5430-5435

2016

Volltextzugriff (PDF)

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model

Frontiers in immunology, 2019-04, Vol.10, p.756-756

2019

Volltextzugriff (PDF)

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

npj vaccines, 2017-09, Vol.2 (1), p.26-26, Article 26

2017

Volltextzugriff (PDF)

Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations

Vaccine, 2019-08, Vol.37 (35), p.4830-4834

2019

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(37)
Vaccines
(30)
Immunology
(23)
Humans
(19)
Medicine, Research & Experimental
(17)
Research & Experimental Medicine
(17)
Antigens
(14)
Pandemics
(13)
Influenza
(12)
Immunogenicity
(10)
Viruses
(10)
Antibodies
(9)
Clinical Trials
(9)
Infections
(9)
Proteins
(9)
Animals
(8)
Influenza, Human - Prevention & Control
(8)
Vaccine
(8)
Bacteria
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prophylaxis and Treatment against Klebsiella pneumoniae : Current Insights on This Emerging Anti-Microbial Resistant Global Threat

Advancing new vaccines against pandemic influenza in low-resource countries

A flow cytometry-based assay to determine the ability of anti-Streptococcus pyogenes antibodies to mediate monocytic phagocytosis in human sera

Towards a Four-Component GMMA-Based Vaccine against Shigella

High yield production process for Shigella outer membrane particles

Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity

A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development

Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Shigella -specific antibodies

Universal influenza vaccines: Shifting to better vaccines

Development and Application of a High-Throughput Method for the Purification and Analysis of Surface Carbohydrates from Klebsiella pneumoniae

A next-generation GMMA-based vaccine candidate to fight shigellosis

A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements

Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adults

Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro

New Kids on the Block: RNA-Based Influenza Virus Vaccines

GMMA-Based Vaccines: The Known and The Unknown

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults

Vaccines for a sustainable planet

Self-Amplifying mRNA Vaccines

Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus

Development and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human sera

Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations

Suchergebnisse filtern